These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36457743)

  • 21. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
    Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
    Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
    Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
    Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients.
    Elfert AY; Salem A; Abdelhamid AM; Salama A; Sourour DA; Shaker O; Keshk M
    Front Mol Biosci; 2022; 9():864839. PubMed ID: 35651814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma.
    Sun L; Xu M; Zhang G; Dong L; Wu J; Wei C; Xu K; Zhang L
    Int J Genomics; 2021; 2021():1326463. PubMed ID: 34988221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
    Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
    Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A miRNA Combination as Promising Biomarker for Hepatocellular Carcinoma Diagnosis: A Study Based on Bioinformatics Analysis.
    Ji J; Chen H; Liu XP; Wang YH; Luo CL; Zhang WW; Xie W; Wang FB
    J Cancer; 2018; 9(19):3435-3446. PubMed ID: 30310500
    [No Abstract]   [Full Text] [Related]  

  • 33. Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasis.
    Wong VC; Wong MI; Lam CT; Lung ML; Lam KO; Lee VH
    J Cancer; 2021; 12(15):4585-4594. PubMed ID: 34149922
    [No Abstract]   [Full Text] [Related]  

  • 34. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
    Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
    PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma.
    Zhao J; Zhu XC; Wu XS; Wang L; Zhu CC; Yang K; Deng GQ; Wang A; Liu Y; Jia WD; Zhu L
    J Cancer; 2020; 11(23):7032-7044. PubMed ID: 33123293
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
    Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
    Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Sun Q; Li J; Jin B; Wang T; Gu J
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.